BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10217594)

  • 1. Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10).
    Aurelian L; Kokuba H; Smith CC
    Vaccine; 1999 Apr; 17(15-16):1951-63. PubMed ID: 10217594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth.
    Smith CC; Peng T; Kulka M; Aurelian L
    J Virol; 1998 Nov; 72(11):9131-41. PubMed ID: 9765459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway.
    Perkins D; Pereira EF; Gober M; Yarowsky PJ; Aurelian L
    J Virol; 2002 Feb; 76(3):1435-49. PubMed ID: 11773417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth.
    Smith CC; Nelson J; Aurelian L; Gober M; Goswami BB
    J Virol; 2000 Nov; 74(22):10417-29. PubMed ID: 11044086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A growth and latency compromised herpes simplex virus type 2 mutant (ICP10DeltaPK) has prophylactic and therapeutic protective activity in guinea pigs.
    Wachsman M; Kulka M; Smith CC; Aurelian L
    Vaccine; 2001 Feb; 19(15-16):1879-90. PubMed ID: 11228357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transmembrane domain of the large subunit of HSV-2 ribonucleotide reductase (ICP10) is required for protein kinase activity and transformation-related signaling pathways that result in ras activation.
    Smith CC; Luo JH; Hunter JC; Ordonez JV; Aurelian L
    Virology; 1994 May; 200(2):598-612. PubMed ID: 8178446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is associated with the virion tegument and has PK activity.
    Smith CC; Aurelian L
    Virology; 1997 Aug; 234(2):235-42. PubMed ID: 9268154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel protein kinase of the RR1 subunit of herpes simplex virus has autophosphorylation and transphosphorylation activity that differs in its ATP requirements for HSV-1 and HSV-2.
    Peng T; Hunter JR; Nelson JW
    Virology; 1996 Feb; 216(1):184-96. PubMed ID: 8614985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10DeltaPK.
    Gyotoku T; Ono F; Aurelian L
    Vaccine; 2002 Jun; 20(21-22):2796-807. PubMed ID: 12034107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for virus growth and neoplastic transformation.
    Smith CC; Kulka M; Wymer JP; Chung TD; Aurelian L
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1417-28. PubMed ID: 1318943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1.
    Perkins D; Pereira EF; Aurelian L
    J Virol; 2003 Jan; 77(2):1292-305. PubMed ID: 12502846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutant type 2 herpes simplex virus deleted for the protein kinase domain of the ICP10 gene is a potent oncolytic virus.
    Fu X; Tao L; Cai R; Prigge J; Zhang X
    Mol Ther; 2006 May; 13(5):882-90. PubMed ID: 16569513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AP-1 cis-response elements are involved in basal expression and Vmw110 transactivation of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
    Zhu J; Aurelian L
    Virology; 1997 May; 231(2):301-12. PubMed ID: 9168892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress up-regulates neuronal expression of the herpes simplex virus type 2 large subunit of ribonucleotide reductase (R1; ICP10) by activating activator protein 1.
    Gober MD; Wales SQ; Hunter JC; Sharma BK; Aurelian L
    J Neurovirol; 2005 Aug; 11(4):329-36. PubMed ID: 16162476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth compromised HSV-2 mutant DeltaRR prevents kainic acid-induced apoptosis and loss of function in organotypic hippocampal cultures.
    Gober MD; Laing JM; Thompson SM; Aurelian L
    Brain Res; 2006 Nov; 1119(1):26-39. PubMed ID: 17020750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel human gene similar to the protein kinase (PK) coding domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) codes for a serine-threonine PK and is expressed in melanoma cells.
    Smith CC; Yu YX; Kulka M; Aurelian L
    J Biol Chem; 2000 Aug; 275(33):25690-9. PubMed ID: 10833516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus type 2 growth and latency reactivation by cocultivation are inhibited with antisense oligonucleotides complementary to the translation initiation site of the large subunit of ribonucleotide reductase (RR1).
    Aurelian L; Smith CC
    Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):77-85. PubMed ID: 10805158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2.
    Wang K; Goodman KN; Li DY; Raffeld M; Chavez M; Cohen JI
    J Virol; 2016 Jan; 90(1):562-74. PubMed ID: 26559846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transmembrane helical segment but not the invariant lysine is required for the kinase activity of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
    Luo JH; Aurelian L
    J Biol Chem; 1992 May; 267(14):9645-53. PubMed ID: 1315764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.